- Home
- HUBS vs BNTX Comparison
HUBS vs BNTX Comparison
Compare HUBS & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBS
- BNTX
- Stock Information
- Founded
- HUBS 2005
- BNTX 2008
- Country
- HUBS United States
- BNTX Germany
- Employees
- HUBS N/A
- BNTX N/A
- Industry
- HUBS Computer Software: Prepackaged Software
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HUBS Technology
- BNTX Health Care
- Exchange
- HUBS Nasdaq
- BNTX Nasdaq
- Market Cap
- HUBS 23.8B
- BNTX 24.8B
- IPO Year
- HUBS 2014
- BNTX 2019
- Fundamental
- Price
- HUBS $395.99
- BNTX $103.75
- Analyst Decision
- HUBS Strong Buy
- BNTX Strong Buy
- Analyst Count
- HUBS 29
- BNTX 13
- Target Price
- HUBS $630.38
- BNTX $139.07
- AVG Volume (30 Days)
- HUBS 867.2K
- BNTX 771.4K
- Earning Date
- HUBS 11-05-2025
- BNTX 11-03-2025
- Dividend Yield
- HUBS N/A
- BNTX N/A
- EPS Growth
- HUBS N/A
- BNTX N/A
- EPS
- HUBS N/A
- BNTX N/A
- Revenue
- HUBS $2,987,698,000.00
- BNTX $3,698,814,972.00
- Revenue This Year
- HUBS $19.81
- BNTX N/A
- Revenue Next Year
- HUBS $16.20
- BNTX $9.49
- P/E Ratio
- HUBS N/A
- BNTX N/A
- Revenue Growth
- HUBS 19.21
- BNTX 3.70
- 52 Week Low
- HUBS $375.01
- BNTX $81.20
- 52 Week High
- HUBS $881.13
- BNTX $129.27
- Technical
- Relative Strength Index (RSI)
- HUBS 34.43
- BNTX 47.12
- Support Level
- HUBS $379.76
- BNTX $100.09
- Resistance Level
- HUBS $405.00
- BNTX $113.39
- Average True Range (ATR)
- HUBS 16.68
- BNTX 3.53
- MACD
- HUBS -7.11
- BNTX -0.01
- Stochastic Oscillator
- HUBS 17.05
- BNTX 25.14
About HUBS HubSpot Inc.
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.